Learn More
Medchemexpress LLC Ars-853 | 1629268-00-3 | 98.39% | 432.94 | 50 MG

Supplier: Medchemexpress LLC HY1970650MG
ARS-853 is a cell-active, selective, covalent KRAS G12C inhibitor with an IC50 of 2.5 μM. It inhibits mutant KRAS-driven signaling by binding to the GDP-bound oncoprotein, thereby preventing its activation.
- Cell-active, selective, covalent KRAS G12C inhibitor.
- Inhibits mutant KRAS-driven signaling by binding to the GDP-bound oncoprotein and preventing activation.
- Reduces the level of GTP-bound KRAS by more than 95% (at 10 μM) in KRASG12C-mutant lung cancer cells.
- Inhibits proliferation with an IC50 of 2.5 μM.
- Selectively reduces KRAS-GTP levels and RAS-effector signaling in KRASG12C-mutant cells.
- Induces apoptosis in four KRASG12C mutant cell lines.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.